Join
Rain Enhancement Technologies Holdco Inc. logo

RAIN

NASDAQ

Rain Enhancement Technologies Holdco Inc.

SectorTechnologyIndustryIndustrial Machinery/Components
$2.15-0.01 (-0.46%)
News25/Ratings8

Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Its lead product candidate is RAIN-32, a small molecule oral inhibitor of mouse double minute 2, which is oncogenic in various cancers. The company is also developing RAIN-32 that has completed Phase II clinical trial in liposarcoma, Phase I clinical trial in solid tumors, and Phase II clinical trial in intimal sarcoma, as well as RAD52 for tumors, including breast, ovarian, prostate, and other cancers. Rain Therapeutics Inc. was incorporated in 2017 and is headquartered in Newark, California.

News · 26 weeks29-86%
2025-12-14: 42025-12-21: 02025-12-28: 42026-01-04: 02026-01-11: 02026-01-18: 02026-01-25: 02026-02-01: 22026-02-08: 12026-02-15: 42026-02-22: 02026-03-01: 02026-03-08: 02026-03-15: 02026-03-22: 02026-03-29: 22026-04-05: 12026-04-12: 32026-04-19: 02026-04-26: 22026-05-03: 22026-05-10: 32026-05-17: 12026-05-24: 02026-05-31: 02026-06-07: 0
2025-12-142026-06-07
Mix1490d
  • SEC Filings7(50%)
  • Market3(21%)
  • Other3(21%)
  • Insider1(7%)

Latest news

25 items

RAIN FAQ

6 questions
  • What does Rain Enhancement Technologies Holdco Inc. do?
    Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Its lead product candidate is RAIN-32, a small molecule oral inhibitor of mouse double minute 2, which is oncogenic in various cancers. The company is also developing RAIN-32 that has completed Phase II clinical trial in liposarcoma, Phase I clinical trial in solid tumors, and Phase II clinical trial in intimal sarcoma, as well as RAD52 for tumors, including breast, ovarian, prostate, and other cancers. Rain Therapeutics Inc. was incorporated...
  • Where does RAIN stock trade?
    Rain Enhancement Technologies Holdco Inc. (RAIN) is listed on NASDAQ.
  • What sector and industry is RAIN in?
    Rain Enhancement Technologies Holdco Inc. operates in the Technology sector, Industrial Machinery/Components industry.
  • What are analysts saying about RAIN?
    Rain Enhancement Technologies Holdco Inc. has had 8 recent analyst actions on file. The most recent action was from ROTH MKM: Neutral on 2023-05-30. Recent price targets range from $1000.00 to $2500.00.
  • What companies are similar to RAIN?
    Notable peers in the same industry include ASML (ASML Holding N.V. New York Registry Shares), LRCX (Lam Research Corporation), TMO (Thermo Fisher Scientific Inc), DE (Deere & Company), ETN (Eaton Corporation PLC). Compare RAIN side-by-side with any of them on Quantisnow.
  • How can I track RAIN on Quantisnow?
    Quantisnow aggregates Rain Enhancement Technologies Holdco Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow RAIN to receive live email and push alerts on every new disclosure.